Common use of Obligations Related to Ongoing Activities Clause in Contracts

Obligations Related to Ongoing Activities. [***] Notice, then Roche (a) shall have the right to cancel all ongoing obligations and (b) shall complete all non-cancellable obligations at its own expense. lf lcagen provides such timely Continuation Election Notice, then from the date of notice of termination until the effective date of termination, Roche shall continue activities, including preparatory activities, ongoing as of the date of notice of termination. However, Roche shall not be obliged to initiate any new activities not ongoing at the date of notice of termination. After the effective date of termination, Roche shall have no obligation to perform and/or complete any activities or to make any payments for performing or completing any activities under this Agreement, except as expressly stated herein. Notwithstanding the foregoing, in case of termination by lcagen under Section 16.2.1 or 16.2.2 or by Roche under Section 16.2.4, upon the request of lcagen, Roche shall complete any Clinical Studies related to the Product(s) that are being conducted under its lND for the Product(s) and are ongoing as of the effective date of termination; provided, however, that

Obligations Related to Ongoing Activities. [***] If BPM does not provide a timely Continuation Election Notice, then Roche each Party (a) shall have the right to cancel all ongoing obligations and (b) shall complete all non-cancellable obligations at its own expenseobligations. lf lcagen If BPM provides such timely Continuation Election Notice, then from the date of notice of termination until the effective date of termination, Roche shall continue activitiesall activities contemplated by this Agreement, including preparatory activities, ongoing as of the date of notice of termination. However, Roche shall not be obliged to initiate any new activities not ongoing at the date of notice of termination. After the effective date of termination, neither Roche nor BPM shall have no an obligation to perform and/or complete any activities or to make any payments for performing or completing any activities under this Agreement, except as expressly stated herein. Notwithstanding the foregoing, in case of termination by lcagen BPM under Section 16.2.1 21.2.1, Section 21.2.2 or 16.2.2 Section 21.2.5 or by Roche under Section 16.2.421.2.4, upon the request of lcagenBPM, Roche shall complete any Clinical Studies related to the Licensed Product(s) that are being conducted under its lND IND(s) for the Licensed Product(s) and are ongoing as of the effective date of termination; provided, however, that